1. Home
  2. RGP vs HUMAW Comparison

RGP vs HUMAW Comparison

Compare RGP & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGP
  • HUMAW
  • Stock Information
  • Founded
  • RGP 1996
  • HUMAW 2004
  • Country
  • RGP United States
  • HUMAW United States
  • Employees
  • RGP N/A
  • HUMAW 220
  • Industry
  • RGP Business Services
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGP Consumer Discretionary
  • HUMAW Health Care
  • Exchange
  • RGP Nasdaq
  • HUMAW Nasdaq
  • Market Cap
  • RGP 178.9M
  • HUMAW N/A
  • IPO Year
  • RGP 2006
  • HUMAW N/A
  • Fundamental
  • Price
  • RGP $5.86
  • HUMAW N/A
  • Analyst Decision
  • RGP Sell
  • HUMAW
  • Analyst Count
  • RGP 1
  • HUMAW 0
  • Target Price
  • RGP $5.00
  • HUMAW N/A
  • AVG Volume (30 Days)
  • RGP 207.1K
  • HUMAW 14.2K
  • Earning Date
  • RGP 07-17-2025
  • HUMAW 03-21-2025
  • Dividend Yield
  • RGP 4.64%
  • HUMAW N/A
  • EPS Growth
  • RGP N/A
  • HUMAW N/A
  • EPS
  • RGP N/A
  • HUMAW N/A
  • Revenue
  • RGP $560,189,000.00
  • HUMAW N/A
  • Revenue This Year
  • RGP N/A
  • HUMAW N/A
  • Revenue Next Year
  • RGP $3.85
  • HUMAW N/A
  • P/E Ratio
  • RGP N/A
  • HUMAW N/A
  • Revenue Growth
  • RGP N/A
  • HUMAW N/A
  • 52 Week Low
  • RGP $4.81
  • HUMAW $1.18
  • 52 Week High
  • RGP $12.19
  • HUMAW $1.34
  • Technical
  • Relative Strength Index (RSI)
  • RGP 64.98
  • HUMAW N/A
  • Support Level
  • RGP $5.23
  • HUMAW N/A
  • Resistance Level
  • RGP $5.41
  • HUMAW N/A
  • Average True Range (ATR)
  • RGP 0.21
  • HUMAW 0.00
  • MACD
  • RGP 0.08
  • HUMAW 0.00
  • Stochastic Oscillator
  • RGP 95.45
  • HUMAW 0.00

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: